Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-transplant cutaneous T-cell lymphomas.

C Lok1, V Viseux, J P Denoeux

  • 1Service de Dermatologie, Centre Hospitalier Universitaire, Hôpital Sud, 80 054 Amiens Cedex 1, France. Lok.catherine@chu-amiens.fr

Critical Reviews in Oncology/Hematology
|July 28, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nailfold capillaroscopy in acrocyanosis among patients with associated Raynaud's phenomenon.

Annales de dermatologie et de venereologie·2024
Same author

Chemotherapy is not needed when complete evacuation of gestational choriocarcinoma leads to hCG normalization.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2024
Same author

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Early involvement of lymphatic vessels in pathophysiology of morphea.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Leg ulcers in childhood: A multicenter study in France.

Annales de dermatologie et de venereologie·2021
Same author

Evaluation of timolol maleate gel for management of hard-to-heal chronic venous leg ulcers. Phase II randomised-controlled study.

Annales de dermatologie et de venereologie·2021

Post-transplant cutaneous T-cell lymphomas are rare but aggressive. Unlike non-immunosuppressed patients, these lymphomas have a poor prognosis, with a high mortality rate within the first year.

Area of Science:

  • Dermatology
  • Oncology
  • Transplantation

Background:

  • Post-transplant cutaneous lymphomas are rare, with cutaneous T-cell lymphomas (CTCLs) comprising 30% of cases.
  • Clinical and histological features of post-transplant CTCLs resemble those in non-immunosuppressed individuals, including plaques, nodules, and erythroderma.

Purpose of the Study:

  • To investigate the clinical presentation, histology, and prognosis of post-transplant cutaneous T-cell lymphomas.
  • To compare the outcomes of post-transplant CTCLs with those of post-transplant B-cell lymphomas and CTCLs in the general population.

Main Methods:

  • Review of clinical data, skin lesion appearance, histology, and immunohistochemistry of post-transplant cutaneous lymphoma patients.
  • Analysis of patient survival and comparison with known outcomes for different lymphoma types and patient populations.

Related Experiment Videos

Main Results:

  • Post-transplant CTCLs present similarly to non-immunosuppressed CTCLs but show a significantly worse prognosis.
  • In a series of 13 patients, 8 died within a year, with 6 deaths occurring within the first year.
  • No viral link was identified for post-transplant CTCLs, unlike some post-transplant B-cell lymphomas.

Conclusions:

  • Post-transplant cutaneous T-cell lymphomas have a poor prognosis, mirroring systemic T-cell lymphomas in transplant recipients.
  • The prognosis for post-transplant CTCLs is less favorable than for post-transplant cutaneous B-cell lymphomas.